₹377.80
+13.40 (+3.68%)
As of 18 Sept 2026, Ind-Swift Laboratories Ltd share price is ₹377.80. The stock opened at ₹377.80 and had closed at ₹364.40 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹87.00 and a high of ₹403.00. In terms of performance, Ind-Swift Laboratories Ltd share price has increased by 150.96% over the past six months and has increased by 247.38% over the last year.
INDSWFTLAB Stock Price Chart
Ind-Swift Laboratories Ltd Overview
Market cap₹3,169 Crs
Volume52,936
Prev. Close₹364.40
Year range₹87.00 - ₹403.00
ISININE915B01019
About INDSWFTLAB
Ind-Swift Laboratories as an API manufacturer the Company has shifted its focus to formulation as its key business driver.
Ind-Swift Laboratories Ltd Historical Performance
1 Month Return16.31%
6 Month Return165.21%
3 Year Return300.22%
3 Month Return123.76%
1 Year Return241.68%
5 Year Return450.04%
Ind-Swift Laboratories Ltd Fundamentals
ROCE(TTM)4.48%
P/E Ratio (TTM)53.83
P/B Ratio2.31
Debt to Equity0.01
ROE3.70%
EPS (TTM)7.68
Dividend Yield0.00%
Book Value157.64
Profit Margin10.09%
Operating Margin5.05%
Ind-Swift Laboratories Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 682.85 | 630.92 | 1,760.87 | 1,185.24 | 1,030.59 |
| EBITDA | 82.19 | 291.54 | 778.11 | 228.73 | 234.52 |
| Net Profit | 42.56 | 256.09 | 536.18 | 42.47 | -5.71 |
| EPS | 5.09 | 38.08 | 90.74 | 7.19 | -0.97 |
Ind-Swift Laboratories Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 330.82 |
| Resistance 1 (R1) | 388.87 |
| Pivot Point | 355.28 |
INDSWFTLAB Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| N R Munjal | Chairman |
| Himanshu Jain | Managing Director |
| Rishav Mehta | Executive Directorector |
Ind-Swift Laboratories Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Ind-Swift Laboratories Ltd today is ₹377.80 on NSE and ₹377.80 on BSE.
- The 52-week high of Ind-Swift Laboratories Ltd is ₹403.00, while the 52-week low is ₹87.00.
- The current market capitalisation of Ind-Swift Laboratories Ltd is approximately ₹3,169 crore.
- The P/E (Price-to-Earnings) ratio of Ind-Swift Laboratories Ltd is 4.14. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Ind-Swift Laboratories Ltd is 0.79. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Ind-Swift Laboratories Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for INDSWFTLAB on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Ind-Swift Laboratories Ltd has delivered a return of approximately 300.22%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Ind-Swift Laboratories Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 42.93% promoters, 10.70% FIIs, 0.17% DIIs, and 34.45% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
